Related Experiment Video
Updated: Jan 27, 2026

Probe-based Confocal Laser Endomicroscopy of the Urinary Tract: The Technique
Published on: January 10, 2013
Confocal Laser Endomicroscopy in the Evaluation of Inflammatory Bowel Disease
1Division of Gastroenterology at University of Pennsylvania, Philadelphia, Pennsylvania.
Insights
Confocal laser endomicroscopy (CLE) enhances endoscopic evaluation of inflammatory bowel disease (IBD) by providing real-time in vivo histology. This advanced imaging aids in assessing mucosal healing and characterizing lesions, improving IBD patient care.
Area of Science:
- Gastroenterology
- Medical Imaging
- Histopathology
Background:
- Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, requires effective monitoring.
- Conventional endoscopy is a key tool for IBD surveillance.
- Limitations exist in assessing mucosal healing and subtle abnormalities with standard endoscopy.
Purpose of the Study:
- To evaluate the utility of confocal laser endomicroscopy (CLE) in conjunction with conventional endoscopy for IBD monitoring.
- To explore CLE's capability for real-time in vivo histological assessment of the intestinal mucosa.
- To determine if CLE can improve the characterization of mucosal lesions and assess epithelial barrier function in IBD.
Main Methods:
- Utilized confocal laser endomicroscopy (CLE) during standard endoscopic procedures in IBD patients.
- Performed real-time visualization of the intestinal mucosa at a microscopic level.
- Assessed epithelial barrier function, vascular permeability, and characterized mucosal lesions, including dysplasia.
Main Results:
- CLE enabled real-time in vivo histology, visualizing mucosal abnormalities not apparent on conventional endoscopy.
- Identified subtle mucosal changes, assessed epithelial integrity, and characterized lesions.
- Demonstrated potential for improved evaluation of mucosal healing and dysplastic changes in IBD.
Conclusions:
- Confocal laser endomicroscopy (CLE) significantly enhances endoscopic evaluation of IBD by providing detailed, real-time mucosal visualization.
- CLE aids in identifying subtle mucosal abnormalities, assessing barrier function, and characterizing lesions, thereby improving IBD assessment.
- Future molecular imaging applications of CLE hold promise for optimizing IBD therapeutic strategies and monitoring treatment response.
Abstract:
Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, can be effectively monitored with the use of endoscopy. The additional application of small field imaging technology such as confocal laser endomicroscopy CLE during ongoing endoscopic evaluation has led to real-time visualization of mucosal abnormalities and thus in vivo histology. The endomicroscopy (CLE) can improve IBD endoscopic evaluation by identifying seemingly normal-appearing mucosa, assessing the function of the intestinal barrier of the epithelium and vascular permeability, and by characterizing any mucosal lesions, including dysplastic lesions. CLE used during conventional endoscopy could especially facilitate the evaluation of mucosal healing in IBD. In addition, future developments in molecular imaging in IBD may optimize therapeutic approaches by identifying mucosal targets for therapy and determining the reasons for lack of response to specific therapy or subsequent loss of the response.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

